Close mobile menu×
Close mobile menu

Rebecca J. Leeman-Neill, MD, PhD

Board Certifications: 
Pathology - Anatomic, Pathology - Hematology
Accepting New Patients
Profile Headshot

Schedule an Appointment

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Board Certifications

  • Pathology - Anatomic
  • Pathology - Hematology

Clinical Expertise

  • Hematology
  • Hematopathology


Education & Training

  • PhD, 2008 University of Pittsburgh
  • MD, 2010 University of Pittsburgh School of Medicine
  • Internship: University of Pittsburgh Medical Center
  • Residency: University of Pittsburgh Medical Center
  • Fellowship: University of Pittsburgh Medical Center

Honors & Awards

2010 Robert E. Lee, MD Award for Excellence in Anatomic Pathology, University of Pittsburgh School of Medicine

2007 AACR-Women in Cancer Research Brigid G. Leventhal Scholar in Cancer Research Travel Award to AACR Frontiers in Cancer Prevention Research \

2007 American Society for Clinical Pathology Award for Academic Excellence and Achievement

2006 Scholar-in-Training Travel Award to AACR Frontiers in Cancer Prevention Research

About Rebecca Leeman-Neill

Academic Titles

  • Assistant Professor of Pathology & Cell Biology

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center


  • Female

Insurance Accepted


  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health


  • Medicare Managed Care
  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan


  • EPO
  • Great West
  • HMO
  • POS
  • PPO


  • Medicare Managed Care
  • PPO


  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Local 1199

  • Local 1199


  • MagnaCare


  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty


  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.


Selected Publications

Soderquist CR, Patel N, Murty VV, Betman S, Aggarwal N, Young KH, Xerri L, Leeman-Neill R, Lewis SK, Green PH, Hsiao S, Mansukhani MM, Hsi ED, de Leval L, Alobeid B, Bhagat G. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract. Haematologica. 2019 Sep 26.

Leeman-Neill, R. J., S. H. Swerdlow, C. L. Burnes, M. A. Melan, M. N. Nikiforova, U. Surti, and N. Aggarwal. Low-level BCR-ABL1 transcripts in individuals without overt hematologic malignancy. Leuk Res. 2019 Jun;81:98-101.

Sun, Y., V. V. Murty, R. Leeman-Neill, C. Soderquist, D. Park, D. B. Neill, G. Bhagat, and B. Alobeid. 2019. Cytogenetic analysis of adult T-Cell leukemia/lymphoma: evaluation of a Caribbean cohort. Leuk Lymphoma. 2019 Jun;60(6):1598-1600.

Leeman-Neill, R. J., J. Lim, and U. Basu. The Common Key to Class-Switch Recombination and Somatic Hypermutation: Discovery of AID and Its Role in Antibody Gene Diversification. J Immunol. 2018 Nov 1;201(9):2527-2529

Chander, U, Leeman-Neill, RJ, Bhagat, G. Pathogenesis of Enteropathy-Associated T Cell Lymphoma. Curr Hematol Malig Rep. 2018 Aug;13(4):308-317.

Efanov AA, Brenner AV, Bogdanova TI, Kelly LM, Liu P, Little MP, Wald AI, Hatch M, Zurnadzy LY, Nikiforova MN, Drozdovitch V, Leeman-Neill RJ, Mabuchi K, Tronko MD, Chanock SJ, Nikiforov YE. Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer. J Natl Cancer Inst. 2018 Apr 1;110(4):371-378.

Leeman-Neill, RJ and Bhagat, G. BCL6 as a therapeutic target for lymphoma. Expert Opin Ther Targets, 2018 Feb; 22(2):143-152.

Bogdanova, TI, Zurnadzhy, LY, Nikiforov, YE, Leeman-Neill, RJ, Tronko, MD, Chanock, S, Mabuchi, K, Likhtarov, IA, Kovgan, LM, Drozdovitch, V, Little, MP, Hatch, M, Zablotska, LB, Shpak, VM, McConnell, RJ, Brenner, AV. "Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort." Br. J. Cancer 2015 Dec; 113(11):1556-64.

Gibson, SE, Leeman-Neill, RJ, Jain, S, Piao, W, Cieply, KM, Swerdlow, SH. "Proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene." Br. J. Hematol 2016 Oct; 175(1):173-5.

Leeman-Neill, R.J., Kelly, L.M., Liu, P., Brenner, A.V., Little, M.P., Bogdanova, T.I., Evdokimova, V.N., Hatch, M., Zurnadzy, L.Y., Nikiforova, M.N., Yue, N.J., Zhang, M., Mabuchi, K., Tronko, M.D., Nikiforov, Y.E. "ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer." Cancer 2014 March; 120(6):799-807.

Leeman-Neill, R.J., Brenner, A.V., Little, M.P., Bogdanova, T.I., Maureen, H., Zurnadzy, L.Y., Mabuchi, K., Tronko, M.D., Nikiforov, Y.E. "RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with I-131 radiation dose and other characteristics." Cancer 2013 May; 119(10): 1792-9

Leeman-Neill, R.J., Seethala, R.R., Singh, S.V., Freilino, M.L., Bednash, J.S., Thomas, S.M., Panahandeh, M.C., Gooding, W.E., Joyce, S.C., Lingen, M.W., Neill, D.B., and Grandis, J.R. "Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma" Cancer Prev Res 2011 Feb; 4(2): 230-7

Wheeler, S.E., Suzuki, S., Thomas, S.M., Leeman-Neill, R.J., Chiosea, S.I., Kuan, C.T., Bigner, D.D., Gooding, W.E., Lai, S.Y., and Grandis, J.R. "Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation" Oncogene 2010 Sep; 29(37): 5135-45

Leeman-Neill, R.J., Cai, Q., Joyce, S.C., Thomas, S.M., Bhola, N.E., Neill, D.B., Arbiser, J.L., and Grandis, J.R. "Honokiol inhibits EGFR signaling and enhances antitumor effects of EGFR inhibitors" Clin Cancer Res 2010 May; 16(9): 2571-9

Leeman-Neill, R.J., Wheeler, S.E., Singh, S.V., Thomas, S.M., Seethala, R.R., Neill, D.B., Panahandeh, M.C., Hahm, E., Joyce, S.C., Sen, M., Cai, Q., Li, C., Johnson, D.E., and Grandis, J.R. "Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3" Carcinogenesis 2009 Nov; 30(11): 1848-56.

Li, C., Sen, M., Leeman-Neill, R.J., Man, D.S., Grandis, J.R., and Johnson, D.E., "Bortezomib upregulates activated STAT3 and synergizes with inhibitors of STAT3 to promote head and neck squamous cell carcinoma cell death" Mol. Cancer Ther. 2009 Aug; 8(8): 2211-20

Lui, V.W., Boehm, A., Koppikar, P., Leeman, R.J., Johnson, D., Ogagan, M., Childs, E., Freilino, M., Grandis, J.R., "Antiproliferative mechanisms of a transcription factor decoy targeting STAT3: the role of STAT1," Molec. Pharm. 2007 May; 71(5): 1435-43

Leeman, R.J., Lui, V.W., Grandis, J.R. "STAT3 as a therapeutic target in head and neck cancer." Expert Opin Biol Ther. 2006 Mar; 6(3):231-41.

Abromson-Leeman, S., Bronson, R., Luo, Y., Berman, M., Leeman, R., Leeman, J., Dorf, M., "T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis," Am. J. Pathol. 2004 Nov;165(5):1519-33

Jensen, B.A., Leeman, R.J., Schlezinger, J.J., Sherr, D.H., "Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study," Environ. Health. 2003 Dec 16; 2(1):16.